Stocks Health care NVNO

NASDAQ · Health care

enVVeno Medical Corp (NVNO)

It posted a net loss of $15.7M. In fiscal 2025 capital spending exceeded operating cash flow by $15.6M. At June 30, 2026 it held $2.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 30, 2026.

Watch NVNO in 60 seconds

Follow NVNO

Free, no password. An email when NVNO files with the SEC.

Key facts about enVVeno Medical Corp

Net worth

enVVeno Medical Corp has a market value (market cap) of $4.5M at the latest share price, and shareholders' equity of $20.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Revenue and profit

In fiscal 2019 revenue was $31.2K (-83.3% year on year), with a net loss of $7.6M.

Cash flow

In fiscal 2025 operations used $15.6M of cash.

Latest report

The latest periodic report (quarterly report, 10-Q) was filed with the SEC on July 30, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR

What enVVeno Medical Corp does

enVVeno Medical Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NVNO.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What enVVeno Medical Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 15, 2026
   Activist stake changed SCHEDULE 13D/A
2. August 21, 2026
   Shelf registration to sell securities S-3
3. August 14, 2026
   Passive stake changed SCHEDULE 13G/A
4. July 30, 2026
   Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$5.37 versus -$11.52.
5. July 14, 2026
   Investor disclosure 8-K
6. May 15, 2026
   Passive stake changed SCHEDULE 13G/A
7. May 15, 2026
   Passive stake changed SCHEDULE 13G/A
8. May 6, 2026
   Quarterly report 10-Q · period to March 31, 2026Diluted EPS -$5.89 versus -$7.75.
9. April 29, 2026
   Quarterly results 8-K
10. March 26, 2026
    Employee stock plan registration S-8

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 14, 2026. Insider transactions on SEC

Insider trades

What the people running enVVeno Medical Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $123.3 worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns NVNO

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Latest filings below 5%: Braeden Lichti 0% (September 15, 2026); Perceptive Advisors LLC 3.5% (August 14, 2026); Nantahala Capital Management, LLC 3.46% (November 14, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 2,351 shares in total, about $15.5K at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NVNO

What does enVVeno Medical Corp do?

enVVeno Medical Corp is a company in the Health care sector, listed on NASDAQ as NVNO. Its shares trade on NASDAQ under the ticker NVNO.

What is enVVeno Medical Corp's net worth?

enVVeno Medical Corp has a market value (market cap) of $4.5M at the latest share price, and shareholders' equity of $20.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is enVVeno Medical Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $15.7M.

When did enVVeno Medical Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 30, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake changed from September 15, 2026.

Similar companies

Compare NVNO with

Compare NVNO with any company

Follow NVNO

Get an email when enVVeno Medical Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow NVNO

Free, no password. An email when NVNO files with the SEC.

Where the numbers come from

Financial figures are the values enVVeno Medical Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.